Search / Trial NCT06226233

Efficacy of Juniver, a Digital Self-help Intervention, on Symptoms of Eating Disorders: A Randomised Controlled Trial

Launched by KING'S COLLEGE LONDON · Jan 17, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Eating Disorders Anorexia Nervosa Bulimia Nervosa Binge Eating Disorder Just In Time Interventions Digital Interventions Mental Health

Description

Background Eating disorders are psychiatric disorders defined by extreme and life-threatening behaviours surrounding weight and food intake. Every year, eating disorders affect 2.4m people in the UK, costing £12bn, and 28.8m in the US, costing $65b (Beat, 2015; Deloitte Access Economics, 2020; The Hearts Minds and Genes Coalition for Eating Disorders, 2021). The problem is growing: hospitalisations for eating disorders are up 84% and over half of female university students report some symptoms of an eating disorder. Symptoms are very disruptive and eating disorders are associated with signi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Aged 16 or over
  • * Live in the UK or the US
  • * Any presence and severity of any eating disorder(s): Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder, Other Specified Feeding and Eating Disorders (OSFED), Avoidant Restrictive Food Intake Disorder (ARFID) and Unspecified Feeding or Eating Disorder (UFED) as measured by the EDE-Q and using item-based algorithms to determine the potential presence of one of these eating disorders
  • * Able to provide informed consent
  • * Willing to provide full contact details including a UK or US address, phone number and email address
  • * Willing to provide contact details for a health care professional with whom they are registered (e.g., a general practitioner or primary care physician) and who the study team can contact if they are concerned about their well-being.
  • Exclusion Criteria:
  • * Lack of access to an iPhone - as Juniver is currently only available for use on the iPhone system.
  • * Partaking in any medically-driven special diets (e.g., linked to Coeliac, Crohn's, PCOS, type 1 or type 2 diabetes) - as these individuals would require more specialist dietary advice than the Juniver program can safely provide. Individuals with these conditions who are not on special diets would be eligible to enrol.
  • * Severe depression as measured by PHQ score \> 20
  • * Active suicidal intent or plan
  • .- Body Mass Index (BMI) \<15
  • * Emergency hospital visit or admission within the last month for an eating disorder or other mental health concern

About King's College London

King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.

Locations

London, , United Kingdom

London, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0